Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016 (2016), Article ID 3528064, 9 pages
http://dx.doi.org/10.1155/2016/3528064
Research Article

CYC1 Predicts Poor Prognosis in Patients with Breast Cancer

Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Received 12 November 2015; Accepted 10 April 2016

Academic Editor: Lance A. Liotta

Copyright © 2016 Yingyan Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. D. F. Hayes, C. Isaacs, and V. Stearns, “Prognostic factors in breast cancer: current and new predictors of metastasis,” Journal of Mammary Gland Biology and Neoplasia, vol. 6, no. 4, pp. 375–392, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. H. S. Rugo, “The importance of distant metastases in hormone-sensitive breast cancer,” Breast, vol. 17, supplement 1, pp. S3–S8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Publisher · View at Google Scholar · View at Scopus
  5. M. G. Vander Heiden, L. C. Cantley, and C. B. Thompson, “Understanding the warburg effect: the metabolic requirements of cell proliferation,” Science, vol. 324, no. 5930, pp. 1029–1033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. J. DeBerardinis, J. J. Lum, G. Hatzivassiliou, and C. B. Thompson, “The biology of cancer: metabolic reprogramming fuels cell growth and proliferation,” Cell Metabolism, vol. 7, no. 1, pp. 11–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Sotgia, D. Whitaker-Menezes, U. E. Martinez-Outschoorn et al., “Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the ‘reverse Warburg effect’ in positive lymph node tissue,” Cell Cycle, vol. 11, no. 7, pp. 1445–1454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Owens, M. Kulawiec, M. M. Desouki, A. Vanniarajan, and K. K. Singh, “Impaired OXPHOS complex III in breast cancer,” PLoS ONE, vol. 6, no. 8, Article ID e23846, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Hu, S. S. Hwang, M. Liesa et al., “Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer,” Cell, vol. 148, no. 4, pp. 651–663, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. V. S. LeBleu, J. T. O'Connell, K. N. Gonzalez Herrera et al., “PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis,” Nature Cell Biology, vol. 16, no. 10, pp. 992–1003, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Wu, Y. Tian, G. Chen et al., “Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells,” Cell Death and Differentiation, vol. 17, no. 1, pp. 109–118, 2010. View at Publisher · View at Google Scholar
  12. A. M. V. Duncan, T. Ozawa, H. Suzuki, and R. Rozen, “Assignment of the gene for the cytochrome c1 subunit of the mitochondrial cytochrome bc1 complex (CYC1) to human chromosome 8q24.3,” Genomics, vol. 19, no. 2, pp. 400–401, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Xia, L. Esser, W.-K. Tang et al., “Structural analysis of cytochrome bc1 complexes: implications to the mechanism of function,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1827, no. 11-12, pp. 1278–1294, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. B. L. Trumpower and R. B. Gennis, “Energy transduction by cytochrome complexes in mitochondrial and bacterial respiration: the enzymology of coupling electron transfer reactions to transmembrane proton translocation,” Annual Review of Biochemistry, vol. 63, pp. 675–716, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Gaignard, M. Menezes, M. Schiff et al., “Mutations in CYC1, encoding cytochrome c1 subunit of respiratory chain complex III, cause insulin-responsive hyperglycemia,” The American Journal of Human Genetics, vol. 93, no. 2, pp. 384–389, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. G. Hardie, “AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 774–785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zhou, W. Huang, R. Tao et al., “Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells,” Oncogene, vol. 28, no. 18, pp. 1993–2002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Yan, O. Tsukamoto, A. Nakano et al., “Augmented AMPK activity inhibits cell migration by phosphorylating the novel substrate Pdlim5,” Nature Communications, vol. 6, article 6137, 2015. View at Publisher · View at Google Scholar
  19. B. Györffy, A. Lanczky, A. C. Eklund et al., “An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients,” Breast Cancer Research and Treatment, vol. 123, no. 3, pp. 725–731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. C. Towler and D. G. Hardie, “AMP-activated protein kinase in metabolic control and insulin signaling,” Circulation Research, vol. 100, no. 3, pp. 328–341, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Nakano, H. Kato, T. Watanabe et al., “AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation,” Nature Cell Biology, vol. 12, no. 6, pp. 583–590, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Sanchez-Alvarez, U. E. Martinez-Outschoorn, R. Lamb et al., “Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin,” Cell Cycle, vol. 12, no. 1, pp. 172–182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Hockenbery, “Targeting mitochondria for cancer therapy,” Environmental and Molecular Mutagenesis, vol. 51, no. 5, pp. 476–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. E. Weinberg and N. S. Chandel, “Targeting mitochondria metabolism for cancer therapy,” Nature Chemical Biology, vol. 11, no. 1, pp. 9–15, 2015. View at Publisher · View at Google Scholar · View at Scopus